Data as of Aug 22
| +0.01 / +0.75%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 3.75, with a high estimate of 3.75 and a low estimate of 3.75. The median estimate represents a +177.78% increase from the last price of 1.35.
The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.